Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
Zeng-Hui Wei, Jagadish Koya, Sandra E. Reznik
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
Rim Hamzé, Etienne Delangre, Stefania Tolu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15287-15287
Open Access | Times Cited: 87
Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 144, pp. 104961-104961
Closed Access | Times Cited: 75
Disentangling Mitochondria in Alzheimer’s Disease
Ashu Johri
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11520-11520
Open Access | Times Cited: 60
Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease
Qianqian Wang, Linyan Duan, Xingfan Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4351-4351
Open Access | Times Cited: 59
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
Zdeněk Fišar
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1676-1676
Open Access | Times Cited: 52
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond
Susan Mills, Bo Yang, Graeme Smith, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding
William B. Grant, Steven M. Blake
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1353-1382
Open Access | Times Cited: 25
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 11
AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice
Mayuri Khandelwal, Kapil Manglani, Prabhat Upadhyay, et al.
Neurobiology of Disease (2022) Vol. 174, pp. 105876-105876
Open Access | Times Cited: 34
Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
Jeffrey L. Cummings, Andrew A. Ortiz, Janelle Castellino, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5727-5757
Open Access | Times Cited: 32
Single Cell/Nucleus Transcriptomics Comparison in Zebrafish and Humans Reveals Common and Distinct Molecular Responses to Alzheimer’s Disease
Mehmet İlyas Coşacak, Prabesh Bhattarai, Philip L. De Jager, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1807-1807
Open Access | Times Cited: 30
A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer’s Disease
Jessica Lynn, Mingi Park, Christiana Ogunwale, et al.
Journal of Alzheimer s Disease (2021) Vol. 85, Iss. 2, pp. 485-501
Closed Access | Times Cited: 33
Circadian Mechanisms in Brain Fluid Biology
Velia S. Vizcarra, Ryann M. Fame, Lauren M. Hablitz
Circulation Research (2024) Vol. 134, Iss. 6, pp. 711-726
Open Access | Times Cited: 5
Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets
Aparna Chauhan, Sachin Dubey, Smita Jain
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Closed Access | Times Cited: 5
Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies
Xiangyuan Meng, Hui Zhang, Zhenhu Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Nanoconjugate Improves Cognitive Deficit and Limits the Pathogenic Tau Burden in Okadaic‐Acid‐Induced Alzheimer's Mice
Qiongdan Liang, Shoubo Xiang, Pengzhen Wang, et al.
Advanced Therapeutics (2025)
Closed Access
Exploring the connection between dementia and cardiovascular risk with a focus on ADAM10
Ana Beatriz Aparecida Targas, Pedro Henrique Moreira Victoriano, M. Garcia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167825-167825
Closed Access
Amyloid β1‐40 Predicts Long‐Term Mortality Rate in Patients With Acute Myocardial Infarction
Aneta Aleksova, Alessandra Lucia Fluca, Alessandro Pierri, et al.
Journal of the American Heart Association (2025)
Open Access
Geroprotective interventions in the 3xTg mouse model of Alzheimer’s disease
Michelle M. Sonsalla, Dudley W. Lamming
GeroScience (2023) Vol. 45, Iss. 3, pp. 1343-1381
Open Access | Times Cited: 11
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance
Maria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono, et al.
EBioMedicine (2025) Vol. 115, pp. 105700-105700
Closed Access
Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice
Tomohiro Umeda, Ayumi Sakai, Keiko Shigemori, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 23
Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β?
Cassandra M. Flynn, Qi Yuan
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
Early Intervention in Cognitive Aging with Strawberry Supplementation
Robert Krikorian, Marcelle D. Shidler, Suzanne Summer
Nutrients (2023) Vol. 15, Iss. 20, pp. 4431-4431
Open Access | Times Cited: 9
Metabolic mysteries of the mind: Investigating type 3 diabetes
Mohd Altaf Dar, Zulfkar Qadrie, Mudasir Maqbool, et al.
Open Health (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top